Skip to content

Search

Discover Series: Cancer

What would you discover to help a child? At The Kids, our researchers are committed to Cancer research that makes a real difference.

Fearless Xander: Why we research children's cancers

Ten-year-old Xander has been through more than most kids of his age – specifically, three-and-a-half years of gruelling chemotherapy to treat leukaemia.

Fearless Mikayla: Why we research Down syndrome

Eight-year-old Mikayla is the miracle child her parents never thought they would have. They’d tried for seven years to have a baby, and when Mikayla was finally born they couldn’t contain their excitement or pride. The fact she had Down syndrome was secondary.

The Power of Why

Our job is to find the answers. It's helping us change kids' lives. See the "why?"s we're asking and answering.

Launching The Kids

Western Australia’s biggest and only medical research institute dedicated to improving kids’ health and wellbeing, has rebranded to The Kids Research Institute Australia.

Helping kids stay safe and strong online

Learn how our research is preventing cyberbullying and supporting kids’ mental wellbeing

The idea that changed kids’ health forever

Hear how one bold idea became a world-leading institute for kids’ health.

How April got her spark back after T1D diagnosis

Discover how our breakthroughs are helping kids with diabetes live longer, safer lives.

A diagnostic test for acute rheumatic fever (pilot study)

Currently there are no diagnostic tests for ARF, and no treatments targeting immune responses to improve disease outcomes.

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

The MELODY Study is a Phase 3 randomized, double-blind, placebo-controlled, single-dose study to determine if MEDI8897 will prevent medically attended Respiratory Syncytial Virus (RSV) -confirmed Lower Respiratory Tract Infection (LRTI) in healthy infants entering their first RSV season.